The Enterprise Value as of December 2024 (TTM) for Pacira BioSciences, Inc. (PCRX) is 1.29B

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.29B. This represents a change of -21.24% compared to the average of 1.64B of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical Enterprise Value (quarterly & annually)

How has PCRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Pacira BioSciences, Inc. over the last ten years is 2.38B. The current 1.29B Enterprise Value has changed 5.33% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Enterprise Value was at its highest in in the March 2022 quarter at 4.20B. The Enterprise Value was at its lowest in in the September 2024 quarter at 1.09B.

Pacira BioSciences, Inc. (PCRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pacira BioSciences, Inc. (PCRX) Average Enterprise Value

How has PCRX Enterprise Value performed in the past?

The current Enterprise Value of Pacira BioSciences, Inc. (PCRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pacira BioSciences, Inc. (PCRX) Enterprise Value vs. Peers

How is PCRX’s Enterprise Value compared to its peers?

Pacira BioSciences, Inc.’s Enterprise Value is greater than Phibro Animal Health Corporation (1.10B), less than Dr. Reddy's Laboratories Limited (1.16T), less than Collegium Pharmaceutical, Inc. (1.78B), greater than Silver Spike Investment Corp. (0), less than Prestige Consumer Healthcare Inc. (4.89B), less than HUTCHMED (China) Limited (2.40B), greater than Incannex Healthcare Limited (25.04M), greater than Eagle Pharmaceuticals, Inc. (19.21M), less than ANI Pharmaceuticals, Inc. (1.62B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Intra-Cellular Therapies, Inc. (8.64B), less than Alkermes plc (4.74B),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.